G1 Therapeutics Inc (GTHX.OQ)
GTHX.OQ on NASDAQ Stock Exchange Global Select Market
20.33USD
3:59pm EST
20.33USD
3:59pm EST
Change (% chg)
$0.34 (+1.70%)
$0.34 (+1.70%)
Prev Close
$19.99
$19.99
Open
$20.16
$20.16
Day's High
$20.44
$20.44
Day's Low
$19.71
$19.71
Volume
53,542
53,542
Avg. Vol
131,507
131,507
52-wk High
$69.23
$69.23
52-wk Low
$15.21
$15.21
About
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $731.75 |
| Shares Outstanding(Mil.): | 28.29 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| GTHX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -1.88 | -- | -- |
| ROI: | -- | 8.92 | 14.45 |
| ROE: | -- | 10.08 | 15.96 |
Estimates